Khiron Life Sciences Corp. 4KH.F Stock
Khiron Life Sciences Corp. Price Chart
Khiron Life Sciences Corp. 4KH.F Financial and Trading Overview
| Khiron Life Sciences Corp. stock price | 0.02 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.02 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 0.02 - 0.02 EUR |
| 52 Week Range | 0.02 - 0.11 EUR |
| Volume | 6.1K EUR |
| Avg. Volume | 394 EUR |
| Market Cap | 6.47M EUR |
| Beta (5Y Monthly) | 3.155844 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4KH.F Valuation Measures
| Enterprise Value | 5.3M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.4009981 |
| Price/Book (mrq) | 0.1728 |
| Enterprise Value/Revenue | 0.328 |
| Enterprise Value/EBITDA | -0.323 |
Trading Information
Khiron Life Sciences Corp. Stock Price History
| Beta (5Y Monthly) | 3.155844 |
| 52-Week Change | -71.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.11 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.02 EUR |
| 200-Day Moving Average | 0.05 EUR |
4KH.F Share Statistics
| Avg. Volume (3 month) | 394 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 232.41M |
| Float | 206.03M |
| Short Ratio | N/A |
| % Held by Insiders | 4.64% |
| % Held by Institutions | 0.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -190.0039% |
| Operating Margin (ttm) | -108.068% |
| Gross Margin | 41.33% |
| EBITDA Margin | -101.66% |
Management Effectiveness
| Return on Assets (ttm) | -20.78% |
| Return on Equity (ttm) | -74.68% |
Income Statement
| Revenue (ttm) | 16.14M EUR |
| Revenue Per Share (ttm) | 0.09 EUR |
| Quarterly Revenue Growth (yoy) | -3.79% |
| Gross Profit (ttm) | 6.37M EUR |
| EBITDA | -16406023 EUR |
| Net Income Avi to Common (ttm) | -30661000 EUR |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.94M EUR |
| Total Cash Per Share (mrq) | 0.009 EUR |
| Total Debt (mrq) | 2.56M EUR |
| Total Debt/Equity (mrq) | 9.46 EUR |
| Current Ratio (mrq) | 2.022 |
| Book Value Per Share (mrq) | 0.125 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15012000 EUR |
| Levered Free Cash Flow (ttm) | -8833852 EUR |
Profile of Khiron Life Sciences Corp.
| Country | Germany |
| State | BC |
| City | Vancouver |
| Address | 500 Burrard Street |
| ZIP | V6C 2B5 |
| Phone | N/A |
| Website | https://khiron.ca |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Q&A For Khiron Life Sciences Corp. Stock
What is a current 4KH.F stock price?
Khiron Life Sciences Corp. 4KH.F stock price today per share is 0.02 EUR.
How to purchase Khiron Life Sciences Corp. stock?
You can buy 4KH.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Khiron Life Sciences Corp.?
The stock symbol or ticker of Khiron Life Sciences Corp. is 4KH.F.
Which industry does the Khiron Life Sciences Corp. company belong to?
The Khiron Life Sciences Corp. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Khiron Life Sciences Corp. have in circulation?
The max supply of Khiron Life Sciences Corp. shares is 294.64M.
What is Khiron Life Sciences Corp. Price to Earnings Ratio (PE Ratio)?
Khiron Life Sciences Corp. PE Ratio is now.
What was Khiron Life Sciences Corp. earnings per share over the trailing 12 months (TTM)?
Khiron Life Sciences Corp. EPS is -0.12 EUR over the trailing 12 months.
Which sector does the Khiron Life Sciences Corp. company belong to?
The Khiron Life Sciences Corp. sector is Healthcare.